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A B S T R A C T
Canine atopic dermatitis is a genetically predisposed inflammatory and pruritic allergic skin disease that is often
complicated by (secondary) bacterial and fungal (yeast) infections. High-throughput DNA sequencing was used
to characterize the composition of the microbiome (bacteria and fungi) inhabiting specific sites of skin in healthy
dogs and dogs with atopic dermatitis (AD) before and after topical antimicrobial treatment. Skin microbiome
samples were collected from six healthy control dogs and three dogs spontaneously affected by AD by swabbing
at (non-) predilection sites before, during and after treatment. Bacteria and fungi were profiled by Illumina
sequencing of the 16S ribosomal RNA gene of bacteria (16S) and the internally transcribed spacer of the ribo-
somal gene cassette in fungi (ITS). The total cohort of dogs showed a high diversity of microbes on skin with a
strong individual variability of both 16S and ITS profiles. The genera of Staphylococcus and Porphyromonas were
dominantly present both on atopic and healthy skin and across all skin sites studied. In addition, bacterial and
fungal alpha diversity were similar at the different skin sites. The topical antimicrobial treatment increased the
diversity of bacterial and fungal compositions in course of time on both AD and healthy skin.
1. Introduction
Atopic dermatitis (AD) in dogs is a genetically predisposed in-
flammatory and pruritic allergic skin disease (Hensel et al. 2015). The
skin microbiome may be the source of secondary infections that can
influence the severity of canine AD (Santoro et al. 2015). Microbial
culture-based studies showed that the most prominent bacterium on
lesional skin of dogs with AD is Staphylococcus pseudintermedius,
whereas Malassezia pachydermatis is the main fungal representative
(Miller et al. 2013). Topical antimicrobial therapy is widely used to
relieve symptoms of AD partly caused by secondary infections (Olivry
et al. 2015).
Compared to human fewer studies focused on the canine skin
microbiome. The relative abundance of the Staphylococcus genus was
increased on the skin of AD dogs compared to healthy controls (Bradley
et al. 2016; Bjerre et al. 2017), and lower bacterial diversity was ob-
served at skin sites affected by AD flares in dogs (Rodrigues Hoffmann
et al. 2014; Bradley et al. 2016). Likewise, fungal marker-gene se-
quences (ITS) revealed that the fungal diversity of lesional skin of
atopic dogs was lower than that of healthy skin (Meason-Smith et al.
2015).
In dogs, specific areas of the skin are prone to be affected by AD
(Favrot et al. 2010). In the present study, we aimed at characterization
by high-throughput sequencing of the DNA of bacteria and fungi in-
habiting the canine skin and compared the differences in microbiome
composition i) at three predilection sites of canine AD (axilla, inguinal,
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periocular regions) and a non-predilection site (the trunk), ii) in health
and AD and iii) before, during and after topical treatment with Ma-
laseb® shampoo containing chlorhexidine 2% and miconazole 2%,
proven to be effective for prevention and control of (secondary) bac-
terial and yeast growth on AD skin and consequent reduction of clinical
symptoms of affected dogs (Mueller et al. 2012; Olivry et al. 2015).
With this exploratory study we intended to report initial descriptive
data before embarking on a large survey.
2. Material and Methods
2.1. Dogs and sampling
Three atopic (AD, females, mean age 4.3 ± 4.0 SD years) and six
healthy (HD, 4 females and 2 males; mean age: 4.75 ± 2.0 SD years)
dogs of different breeds (Table S1) housed in the premises of the
Department of Clinical Sciences of Companion Animals, Utrecht
University were included. The three AD dogs were Bedlington-Beagle
crossbreeds whereas the healthy dogs included three Bedlington-Beagle
crossbreeds, two Beagles and one Greyhound. The AD dogs met the
Favrot’s diagnostic criteria for AD, and other causes of pruritus were
ruled out by direct examination of the presence of fleas and flea faeces,
coat brushing and skin scrapings (Hensel et al. 2015). Anti-parasitic
control was achieved by monthly spot-on treatment with selamectin.
Skin cytology was performed to rule out pyoderma and Malassezia
dermatitis. Finally, the animals were fed an elimination diet for at least
8 weeks where food allergy was ruled out when no improvement on the
diet was observed. For all nine dogs enrolled (Fig. 1), hair was clipped
at three lesional sites (axillae, inguinal and periocular) and one non-
lesional site (craniolateral trunk), and skin microbiome samples were
collected by swabbing. A new pair of gloves was used for swabbing each
sample. Sterile swabs (Isohelix DNA Buccal Swabs, Cell Projects Ltd,
UK) were pre-moistened with either a sterile solution of 50mM Tris
buffer [pH 8], 1mM EDTA, and 0.5% Tween-20 or a sterile phosphate
buffered saline (PBS), for bacterial and fungal DNA isolation respec-
tively. Swabs were placed parallel to the skin surface and rubbed back
and forth for approximately 30 s. Initially, all healthy control dogs
(n= 6) were enrolled in the comparison of skin microbiome composi-
tions of different AD predilection sites. Thereafter, sex- and breed-
matched healthy control (HD, n= 3) and AD (n=3) dogs were kept
untreated for four weeks and were subsequently subjected to topical
antimicrobial therapy with Malaseb® shampoo (Dermcare-vet Pty Ltd,
Brisbane, Australia) twice weekly for three weeks. Finally, they were
again kept untreated for four weeks. Sampling was conducted as fol-
lows: t0: before start of treatment; t1: after three weeks of treatment; t2:
four weeks after finalizing the 3-week treatment cycle; tf: upon occur-
rence of flare-up symptoms in the period between t1 and t2 (Fig. 1).
Three AD dogs had AD lesions (erythema, lichenification, excoriations,
self-induced alopecia) when the diagnosis was made, and in one of the
three AD dogs AD lesions flared mainly at the inguinal area, axillae,
forelimbs and hindlimbs after discontinuation of topical treatment (t2).
CADESI-03 scores of the AD dogs were between 0 and 116 at the start of
the experiment and as a result of bathing the scores improved to be-
tween 0 and 33. Healthy dogs enrolled in this study did not have any
skin lesions throughout the experiment. The Malaseb® shampoo was
applied both on AD and healthy dogs to create similar treatment con-
ditions for comparison of microbiome changes. All experimental pro-
cedures were approved by the Utrecht University Animal Ethic com-
mittee as required under Dutch legislation (DEC 2013.II.06.069 and
DEC 2013.II.07.83)
Fig. 1. Study design and timeline of topical antimicrobial treatment.
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2.2. Microbial DNA extraction for marker gene sequencing
To release bacteria (16S), the cotton tips of swabs were repeatedly
pressed against the wall of tubes containing 300 μl Microbead solution
(MO BIO Ultraclean™ Microbial DNA Isolation Kit, MO BIO Laboratories
Inc., Carlsbad, USA). Each tube was vortexed at maximum speed with
the MO BIO Vortex Adapter tube holder (MO BIO Laboratories Inc.,
Carlsbad, USA) for 10minutes and microbial DNA was isolated ac-
cording to the manufacturer’s description. The microbial DNA samples
were stored at −20 °C until further use.
For analysis of fungi (ITS) the cotton tips of the swabs were in-
dividually stored in 300 μl lysis solution (MasterPure™ Yeast DNA
Purification kit, Epicentre, Madison, USA) at 4 °C. Then, 20mg/ml ly-
sozyme (Sigma-Aldrich, St. Louis, USA) was added to the samples and
incubated for 1 h while shaking (220 rpm) at 37 °C, finally, the cotton
tips were removed using sterile forceps. Next, a 5mm steel bead was
added to mechanically disrupt fungal cell walls in samples using a
Tissuelyser (Qiagen, Valencia, USA) for 2min at 30 Hz. The Invitrogen
PureLink Genomic DNA Kit (Invitrogen, Carlsbad, USA) was utilized for
all subsequent steps. The microbial DNA samples were stored at −20 °C
until further use.
2.3. Microbial DNA amplification for marker gene sequencing
Since according to a previous study in humans (Zeeuwen et al.
2012), only low amounts of microorganism DNA was found on skin as
analyzed by PCR, a nested PCR was applied in the present study. In the
first round of PCR, universal primers (16S: 200 nM forward primer
(338 F), 5’-ACT CCT ACG GGA GGC AGC AG-3’, 200 nM reverse primer
(1061R), 5’CRR CAC GAG CTG ACG AC-3’; ITS: 400 nM forward primer
(ITS1F), 5′-CTT GGT CAT TTA GAG GAA GTA A-3′, 400 nM reverse
primer (ITS4R), 5′-TCC TCC GCT TAT TGA TAT GC-3′) were used to
generally amplify the genomic DNA of the V3-V6 region of the 16S
rRNA genes, and the ITS1-ITS2 region of the ITS genes, respectively. In
the second round of PCR, flagged specific primers were used covering
V3-V4 (16S) and ITS1-ITS2 (ITS) regions, resulting in barcoded pro-
ducts; for 16S: 200 nM forward primer (357 F), 5’-TCG TCG GCA GCG
TCA GAT GTG TAT AAG AGA CAG NNN NNN CCT ACG GGA GGC AGC
AG-3’, 200 nM reverse primer (802RV2), 5’-GTC TCG TGG GCT CGG
AGA TGT GTA TAA GAG ACA GTA CNV GGG TAT CTA AKC C-3’; and
for ITS: 40 nM forward primer (ITS86 F), 5’- TCG TCG GCA GCG TCA
GAT GTG TAT AAG AGA CAG NNN NNN NNG TGA ATC ATC GAA TCT
TTG AAC-3’, 40 nM reverse primer (ITS4R), 5′ GTC TCG TGG GCT CGG
AGA TGT GTA TAA GAG ACA GTC CTC CGC TTA TTG ATA TGC-3′; the
italicized sequence is the flag sequence, N is the designated barcode
(adaptor) to tag each product individually and the bold sequence is the
universal primer sequence. Optimal PCR conditions (50 μl reaction
volume) were as follows: 5 μl of 10xKOD buffer, 5 μl of KOD dNTPs, 3 μl
of KOD MgSO4, forward and reverse primer, 1 μl of KOD hot start DNA
polymerase (Novagen®, Osaka, Japan) and ultrapure water (Milli-Q™)
for each reaction. All reactions were initiated at 95 °C for 2min; fol-
lowed by cycles of 95 °C for 20 s, 55 °C for 10 s, and 70 °C for 15 s for
both 1st and 2nd rounds of PCR. Numbers of cycles for 1st and 2nd PCR
were 30 and 35 for 16S respectively 25 and 25 for ITS. Each PCR
product was examined for product size by electrophoresis on a 1%
agarose gel and purified using a MSB Spin PCRapace kit (Invitek Inc.,
Carlsbad, USA) and a PureLink PCR purification kit (Invitrogen,
Carlsbad, USA) for the initial and second (barcoding) PCR, respectively.
2.4. 16S and ITS marker gene sequencing
The skin microbiome compositions were determined by sequencing
of the PCR products of the bacterial and fungal marker genes 16S ri-
bosomal RNA gene (16S) and the internal transcribed spacer (ITS). For
this purpose, Illumina 16S rRNA and ITS amplicon libraries were gen-
erated from the microbial DNA isolated and barcoded as described
above. Aliquots of minimally 100 ng per sample and a 260/280 ratio
ranging between 1.8 and 2.0 were pooled and multiplexed libraries
were sequenced by BaseClear BV (Leiden, The Netherlands), on an
Illumina MiSeq system with a paired-end 300 cycles protocol and in-
dexing. The sequencing run was analyzed with the Illumina CASAVA
pipeline (v1.8.3) with demultiplexing based on sample-specific bar-
codes. The raw sequencing data produced were processed removing the
sequence reads of too low quality (only "passing filter" reads were se-
lected) and discarding reads containing adaptor sequences or failing
PhiX Control with an in-house filtering protocol. A quality assessment
on the remaining reads was performed using the FASTQC quality con-
trol tool version 0.10.0.
2.5. Illumina sequence data analysis
Demultiplexed FASTQ files as provided by BaseClear were first used
to generate Illumina paired-end sequence pseudoreads by PEAR (Zhang
et al. 2014), using the default settings. For gene sequencing analysis, a
customized Python workflow based on Quantitative Insights Into Mi-
crobial Ecology (QIIME version 1.8) (Caporaso et al. 2010) was adopted
(http://qiime.org). Reads were filtered for chimeric sequences using the
UCHIME algorithm version 4 (Edgar et al. 2011). Open reference OTU
calling for taxonomic classification of sequencing reads was performed
with USEARCH version 6.1 (Edgar, 2010) as implemented in QIIME
against the Greengenes database version 13_8 for bacterial sequences
(DeSantis et al. 2006), and against the UNITE database version 12_11
for fungal sequences (Koljalg et al. 2005). Hierarchical clustering of
samples was performed using UPGMA with weighted UniFrac as a
distance measure as implemented in QIIME. Figures resulting from
these clustering analyses were generated using the interactive tree of
life (iTOL) tool (Letunic and Bork, 2007). Alpha diversity metrics
(phylogenetic diversity whole tree (PDWT), Chao1, Observed Species
and Shannon) were calculated by bootstrapping 10 reads per sample,
and taking the average over ten trials. For visualization of the differ-
ential microbiome, Cytoscape software version 3.1 3 (Shannon et al.
2003) was used together with in-house developed Python scripts for
generating the appropriate input data deriving from the QIIME analysis.
Fold changes in abundances of bacterial and fungal genera between
healthy and AD samples of the four skin sites (the 2-log of the ratio
Healthy/AD) are shown in Table 1 and Table 2 respectively, as heat-
maps, created by the Excel version 2010 using the color scales of con-
formational formatting. Individual microbiota were ranked according
to averaged relative abundances in the AD skin samples.
The average sequence read count per sample of this study was
31182 ± 5834 SD and 49064 ± 11846 SD, for 16S and ITS respec-
tively, and likewise, the average number of operational taxonomic units
(OTUs) per sample was 3053 ± 881 SD and 341 ± 158 SD. Three 16S
samples were excluded from further analyses, one due to a low number
of reads (44) and two others due to low OTU counts (148 and 169) (see
more details in Tables S2 and S3). For an overview of the exact (16S and
ITS) microbiome composition for each study sample we refer to Tables
S4 and S5. Note that due to technical limitations in the resolution of 16S
and ITS marker gene sequencing, OTUs calling on the level of species
should be interpreted with caution.
2.6. Statistics
For the microbiome data in this manuscript, statistical significance
between contrasts with regard to taxonomy abundances was tested by a
non-parametric (unpaired) Mann-Whitney U test (MWU), uncorrected
for multiple testing; unless stated otherwise. Note that in the case of
uncorrected p-values, the p-value threshold that needs to be met in
order to be considered significant is adapted by dividing the classic
threshold of P = 0.05 by the number of taxa observed. Statistical tests
were performed by custom, in-house Python scripts (SciPy module
version 0.17.0; https://www.scipy.org/) downstream of QIIME, as
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described above. Principal component analysis (PCA) as well as mul-
tivariate Redundancy Analysis (RDA) were done using Canoco 5.04
(Cajo et al., 2012) using default settings of the analysis type ‘Un-
constrained’ or ‘Constrained’, respectively. Canoco reported variance
explained by particular variables (e.g. breed and site) by applying said
variables as single supplementary variables in a PCA analysis. Relative
abundance values for taxa were used as response data, and for RDA, the
sample classes as explanatory variables. RDA calculates P values by
permuting the sample classes. Significances mentioned in figures are as
follows: n.s. (not significant), * P < 0.05.
2.7. Accession numbers
The raw, unprocessed 16S rRNA and ITS marker gene Illumina se-
quence reads are publicly available for download at the European
Nucleotide Archive (ENA) database (Leinonen et al. 2011) under study
accession number: PRJEB20808 (http://www.ebi.ac.uk/ena/data/
view/PRJEB20808) or secondary accession number: ERP022994
(http://www.ebi.ac.uk/ena/data/view/ERP022994). The sequencing
data are available in FASTQ-format, includissng corresponding meta-
data for each sample. For additional information on sample character-
istics we refer to Table S1.
3. Results
3.1. Canine skin microbiome: general aspects
3.1.1. Study demographics and overview of canine skin microbiome
Bacterial (16S) and fungal (ITS) microbiome compositions of both
healthy and AD dog skin at four different sites (axilla, inguinal, perio-
cular and trunk) and at three different time-points (before, during and
after Malaseb® treatment) were assessed by a PCA at the genus-level.
PCA showed clear separation (variance) between sample groups
(Fig. 2). Most notably, distances between sample sites were less than
those between health and AD states or between time-points around
treatment (Malaseb® treatment effect) for both 16S and ITS, indicating
that there is more overlap between microbiome composition and
abundance between different skin niches than between health states
and between stages (i.e. effect) of treatment.
3.1.2. Comparison of microbiome composition on different (non-)
predilection skin sites within healthy or AD dogs
In RDA, the bacterial and fungal skin microbiome composition on
genus-level in healthy dogs did not differ significantly between skin
niches defined as AD predilection (axilla, inguinal and periocular) or
non-predilection (trunk) sites, for 16S (P = 0.2) nor ITS (P= 0.3).
Accordingly, a clear clustering of samples collected from similar body
sites based on microbiome composition was not observed (Figs. S1-S4).
However, the samples collected from different skin sites of the same
individual did show a certain degree of variation in microbial compo-
sition (both 16S and ITS) but samples from the same breed were at
relatively close distance. For 16S, 47.0% of the variation was explained
by individual differences, 30.7% by breed and 11.6% by sampling site
(Fig. S5A). For ITS, these figures were 40.0%, 28.0% and 10.8% re-
spectively (Fig. S5B). Notably, separation based on breed is more con-
vincing for ITS than for 16S, supported by (beta diversity) clustering of
samples based on full community composition (Figs. S1-S2).
3.2. Comparison of skin microbiome composition between healthy and AD
skin
3.2.1. Alpha diversity
The differences in alpha diversity of bacteria (Fig. 3A) nor fungi
(Fig. 3B) were statistically significant between corresponding AD and
Table 1
Differential presence of bacteria (16S) in the skin microbiome on different body sites of AD and healthy skin.
Listed are the 20 (out of 496) on average most abundant bacterial genera of atopic dermatitis dogs from three
predilection sites: axilla, inguinal region and periocular, and one non-predilection site: trunk. Ranking is based
on the averaged relative abundances of bacteria of the four skin sample sites in the three AD dogs. The
heatmap presents the fold changes in abundance (the 2-log of the ratio Healthy/AD): 1 means two times more
abundant in healthy samples, -1 means two times more abundant in AD samples, 0 means no change, etc.
Significant differences (* P<0.05) in relative abundance of genera in AD compared to healthy skin at the
same sampling site were determined by MWU. A Bonferroni-corrected P value threshold for significance is the
genus-level P value divided by the number of total genera identified, 0.05/496 = P < 1.0*10-4. For abun-
dances of the remaining genera and other taxon levels, see Table S4.
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healthy skin sites; nevertheless, alpha diversity tended to be lower in
AD skin at most sites studied (Fig. 3A–B).
3.2.2. Differential composition of the microbiome on different body sites
between AD and healthy skin
Based on RDA, differences in genera contributing to the microbiome
composition of both 16S and ITS associated to disease status (AD versus
healthy) were not statistically significant (data not shown). The pre-
dominant genera based on body sites and health states are shown in
Table 1 (16S) and Table 2 (ITS).
In both AD and healthy dog skin, the bacterial microbiome com-
position differed only slightly among skin sites studied (Table 1). The,
on average (across all skin sites), most abundant bacteria observed in
AD skin were Staphylococcus, Psychrobacter, Trichococcus, Brachy-
bacterium and Porphyromonas. These genera were also present on
healthy skin but varied in the relative abundance. The most dominant
bacterial (genus-level) taxa shared between all four body sites in
healthy skin are Pseudomonas (5.61%±1.96% SEM), Kocuria
(5.29%±0.62%), Porphyromonas (4.31%±1.52%), Staphylococcus
(3.65%±0.72%) and Corynebacterium (3.31%±1.08%) (Table S4).
Differences were observed in the order of the top abundant taxa among
the sample sites of dogs with AD (Table 1). Staphylococcus was always
more abundant in AD skin than in controls at the same sites (axilla:
14.46% versus 5.02%; inguinal 36.50% versus 4.26%; periocular
30.46% versus 3.66%; trunk 6.95% versus 1.66%) (Fig. S6, t0 results),
although this did not reach statistical significances. In samples of le-
sional sites of AD dogs during flare-up the presence of Staphylococcus
was the most abundant among the bacterial microbiome community
(21.74 ± 8.29% SEM). Interestingly, the relative abundances of the
lowly dominant Microbacterium were significantly lower at each of the
three predilection sites in AD dogs as compared to those in healthy ones
(Table 1). In contrast, for none of the 496 bacterial genera significant
differences in relative abundance were found between AD and healthy
trunk skin, considered to be a non-predilection site.
The most abundant fungal genera, found on the healthy skin across
all sites studied were “Unidentified#01”, a known classifiable fungal
taxon but currently without assigned nomenclature, (17.28%±3.26%
SEM), “Unidentified#12” (7.97%±1.01%), Epicoccum (4.02%±0.63%),
Blumeria (2.68%±0.32%) and Ramularia (2.66%±2.31%). Like in
healthy skin, “Unidentified#01” was the most abundant at every AD skin
site studied (Table 2), and this genus was also the most dominant taxon
of fungi presenting during flare-up of AD (15.46%±1.79% SEM).
The largest differences in relative abundances at fungal genus-level
between AD and healthy skin were those observed for Blumeria. These
were statistically significant increases at axilla, inguinal and trunk of
AD skin (Table 2 and Fig. S7, t0).
3.3. Topical antimicrobial treatment with Malaseb® shampoo
3.3.1. The effect of treatment on the diversity of the microbiome on canine
skin
Bacterial and fungal diversities on healthy as well as AD skin, did
not differ significantly at the three different time-points, before, during
and after treatment (see Fig. S8). Interestingly, however, the trend
observed in the bacterial diversity in AD skin was an initial increase
from t0 (start of treatment after at least 4 weeks without intervention)
to t1 (termination of treatment) and a subsequent decrease to the level
of t0 in the four weeks towards t2. The fungal diversity at both AD and
Table 2
Differential presence of fungi (ITS) in the skin microbiome on different body sites of AD and healthy skin.
Listed are the 20 (out of 314) on average most abundant fungal genera of atopic dermatitis dogs from three
predilection sites: axilla, inguinal region and periocular, and one non-predilection site: trunk. Ranking is based on
the averaged relative abundances of fungi of the four skin sample sites in the three AD dogs. The heatmap presents
the fold changes in abundance (the 2-log of the ratio Healthy/AD): 1 means two times more abundant in healthy
samples, -1 means two times more abundant in AD samples, 0 means no change, etc. Note that “Unidentified”
genera represent known classifiable taxa but currently without assigned nomenclature. Significant differences (*
P < 0.05) in relative abundance of genera in AD compared to healthy skin at the same sampling site were de-
termined by MWU. A Bonferroni-corrected P value threshold for significance is the genus-level P value divided by
the number of total genera identified, 0.05/314 = P < 1.6*10-4. For abundances of the remaining genera and
other taxon levels, see Table S5.
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healthy skin decreased towards t1 and had increased at t2, close to that
at t0. In addition, although not statistically significant, a lower diversity
was observed in AD skin as compared to healthy skin at all time-points.
3.3.2. The effect of topical treatment on 16S and ITS microbiome
composition
Topical treatment of dog skin caused changes in 16S microbiome
composition (AD and healthy skin data combined) in course of time. A
clear separation between time-points, as a result of treatment, (3 dif-
ferent colored ovals) was seen in axilla (Fig. 4A; P = 0.026), inguinal
(Fig. 4B; P= 0.032), periocular region (Fig. 4C; P = 0.004) and trunk
(Fig. 4D; P = 0.028).
Likewise, the ITS microbiome composition (AD and healthy skin
data combined) at all sample sites changed significantly in course of
time (axilla and trunk, Fig. 5A and D at P= 0.001; inguinal, Fig. 5B at
P = 0.019; periocular, Fig. 5C at P = 0.049).
Hence, both the differences in bacterial (16S, Fig. 4) and fungal
(ITS, Fig. 5) skin composition in course of time (treatment effect) were
statistically significant if samples were not stratified on health condi-
tion (i.e. analysis irrespective of AD).
3.3.3. The most notable changes as a result of topical treatment
The most notable changes in the microbiome, as a result of treat-
ment were observed in the genus Epicoccum (ITS) (Fig. S9). In AD dogs,
the genus of Blumeria revealed the largest changes in the relative
abundance determined by time-points of sampling (treatment effect) in
comparison to the other fungal genera identified (Fig. S7). Its abun-
dance was high in untreated AD skin (t0), decreased after treatment (t1)
and remained low until four weeks after treatment withdrawal (t2) (Fig.
S7; for axilla, trunk and inguinal). The abundance of Blumeria on
healthy skin was constantly low at all time-points and clearly lower
than that on AD skin.
Fig. 2. Bacterial and fungal genus-level compositions of all study samples indicate a higher microbial similarity between sample sites than between health states or
treatment stages. These representations of a principal component analysis (PCA) of both 16S (A) and ITS (B) datasets reflect the distances between study samples
based on genus-level microbial composition and abundances for each sample. Centroids representing samples of the same sample group are shown as colored symbols
accompanied by their respective labels ( skin site: axilla, inguinal, periocular, trunk; health status: AD, healthy; time-point during Malaseb® treatment: t0
before washing, t1 after three weeks of washing, t2 four weeks after termination of washing). The blue arrows point to the genera (names shown in italics) explaining
compositional differences between the samples. Note that “Unidentified” genera represent known classifiable taxa but currently without assigned nomenclature.
Fig. 3. Phylogenetic Diversity Whole tree (PDWT) analysis of 16S and ITS data. The diversity analyzed by PDWT of 16S (A) and ITS (B) microbiome profiles observed
in atopic dermatitis (AD) and healthy (HD) skin at the four sites studied (Ax: axilla, In: inguinal, Pe: periocular, Tr: trunk).
S. Chermprapai et al. Veterinary Microbiology 229 (2019) 90–99
95
4. Discussion
This study aimed to investigate both the bacterial (16S) and fungal
(ITS) skin microbiome compositions, both in different individuals, at
different predilection sites and with respect to the health status (AD
versus healthy). Furthermore, changes were recorded in the micro-
biome composition after topical treatment with Malaseb® shampoo, a
common choice of treatment known to reduce the clinical severity of
AD most likely partly due to (secondary) infection.
Analysis of the skin 16S and ITS microbiome composition in the
present cohort of dogs revealed a strong inter-dog variability (in-
dividual), whereas breed effects were considerable, but less. In samples
collected from different body sites both from AD and healthy dogs, no
significant differences in microbiome composition (both 16S and ITS)
were found. This confirms findings of another study on fungal
composition of canine skin (Meason-Smith et al. 2015). In contrast, on
human skin the microbiome composition was shown to differ de-
pending on body sites (Grice et al. 2009; Findley et al. 2013), however
comparison of microbiome compositions between human and canine
skin is complicated due to strongly differing microbiomes. Moreover in
dogs alpha diversity of skin microbiome was considerably higher than
that in humans (Zeeuwen et al. 2012; Takemoto et al. 2015).
Comparing AD and healthy skin microbiome profiles, no significant
differences in the alpha diversity were found, only a trend of reduced
16S and ITS diversity in AD compared to control skin. A similar trend
was reported in other canine studies (Rodrigues Hoffmann et al. 2014;
Meason-Smith et al. 2015; Bradley et al. 2016). The topical treatment
increases the diversity of bacteria, but the opposite effect was observed
for fungal diversity. Those non-significant changes, that may be ex-
plained by difference between broad antibacterial and antifungal effects
Fig. 4. Treatment effect on 16S profiles at different body sites. The16S microbiome composition associated to Malaseb® treatment at axilla (A), inguinal (B),
periocular (C) and trunk (D), based on all data (irrespective of health status) visualized in a redundancy analysis (RDA) plot (Treatment was used as explanatory
variable, corrected for Health Condition). Each small open circle represents the skin genus-level composition of one sample. The red triangles are the centroids of the
sample groups for each time point t0, t1 and t2, whereas the colored sample overlays represent the sample clusters per time-point; orange: t0, green: t1 and blue: t2).
Blue arrows: taxa that most contribute to the separation on samples in the respective directions. Significance level at P<0.05.
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of the shampoo, and in potential differences in population dynamics
amongst bacteria and fungi after treatment, need to be confirmed in
larger studies. However, treatment with an antimicrobial shampoo,
known to successfully alleviate clinic symptoms of AD, significantly
changed both 16S and ITS profiles of the microbiome in course of time
and at every site studied but irrespective of AD skin status. Only the
genus, Blumeria (ITS), showed considerable changes in relative abun-
dance determined by both health status and treatment effect. Whether
these changes are affected by the atopic dermatitis directly or the as-
sociated inflammation, or by both, is unclear. The significant increase
of this genus (P < 0.05; uncorrected) observed on AD as compared to
healthy skin in the present study, even though it contrasts findings in an
earlier study of fungi on canine skin (Meason-Smith et al. 2015), war-
rants further studies on the relationship between skin health status and
Blumeria.
In the present study, the bacterial genera Staphylococcus and
Porphyromonas were dominantly present in both AD and healthy skin.
The finding of Staphylococcus as the predominant colonizer of the 16S
profile on AD skin is consistent with many other studies in canine
(Rodrigues Hoffmann et al. 2014; Bradley et al. 2016), feline (Older
et al. 2017) and human skin (Grice et al. 2009; Kong et al. 2012).
Staphylococci are common commensals on the canine skin (Weese,
2013). Porphyromonas, commonly found in the canine oral cavity
(Falagas and Siakavellas, 2000), may have been transferred to skin by
licking, presumably more frequently in AD dogs due to itch. Other
genera present on healthy skin, Kocuria, Pseudomonas and Cor-
ynebacterium are common to dog skin (Weese, 2013; Rodrigues
Hoffmann et al. 2014). The abundance of the low abundant Micro-
bacterium was significantly different (P < 0.05; uncorrected) when
compared between AD and control skin on all predilection sites but not
Fig. 5. Treatment effect on ITS profiles at different body sites. The ITS microbiome composition associated to Malaseb® treatment at axilla (A), inguinal (B),
periocular (C) and trunk (D), based on all data (irrespective of health status) visualized in a redundancy analysis (RDA) plot (Treatment was used as explanatory
variable, corrected for Health Condition). Each small open circle represents the skin genus-level composition of one sample. The red triangles are the centroids of the
sample groups for each time point t0, t1 and t2, whereas the colored sample overlays represent the sample clusters per time-point; orange: t0, green: t1 and blue: t2).
Blue arrows: taxa that most contribute to the separation on samples in the respective directions. Significant level at P < 0.05.
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on the trunk (non-predilection). The observed significant differences in
the lowly abundant genera might be due to the reduced alpha diversity
observed in the AD skin microbiome.
The most abundant fungal genera on both canine AD and healthy
were “Unidentified#01”, “Unidentified#12”, Blumeria and Epicoccum.
Due to technical limitation of ITS marker gene analyses,
“Unidentified#01” can only be qualified as not belonging to the phyla
Ascomycota or Basidiomycota, and “Unidentified#12” as belonging to the
phylum Ascomycota. Malassezia one of the most dominant yeasts (fungi)
reported on canine skin (Meason-Smith et al. 2015), when it comes to
identification of the microbiota composition by culture, was hardly
detected in the present ITS marker gene analysis, that has shown to
readily detect Malassezia if used as a positive control. Apparently, the
skins of dogs in our study are virtually devoid of the Malassezia genus
(presence of 0.02% on average). The ITS sequencing data was scruti-
nized by aligning the raw sequencing data by hand to the representative
Malassezia ITS genus sequence to ensure that Malassezia reads were
indeed not missed even in the raw sequencing data (results not shown).
The apparent discrepancy between Malassezia presence as described in
the literature and our study may be partially explained by housing
condition and/or a small sample size of our study. The other limitations
of our study include varied CADESI scores, mild secondary infections
and low breed diversity.
Obviously additional factors giving rise to abnormalities as reflected
in AD such as skin barrier function, immune responses, genetic back-
ground, etc., may affect the microbiome composition (Santoro et al.
2015; Chermprapai et al. 2018). Differences in skin health caused by
AD might alter its capacity to deal with changes in microbiome com-
position (Santoro et al. 2015; Bradley et al. 2016). Interaction between
microbiome and AD is likely to be a two-way street where microbiome
and disease factors influence each other (Santoro et al. 2015; Bjerre
et al. 2017). The predominant taxa and multiple factors potentially
disturbing skin integrity in AD-related circumstances should be further
investigated in a larger study.
5. Conclusion
Taken together, this study shows that the variation in microbiome
composition of canine skin is likely to be dependent on individuality,
and to a lesser extent is determined by skin site, health status or
treatment effect. However, in some specific taxa significant differences
could be observed by disease or treatment effect that need to be further
investigated.
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